Monolithic Power Systems Inc. (MPWR) continues to make a significant impact in the bio-tech market. It saw considerable movement from several investment firms, with entities like RFG Advisory LLC, GAMMA Investing LLC and Congress Asset Management Co., investing millions into the company, while entities like Toronto Dominion Bank and Tidal Investments LLC reduced their stakes. The company received a notable price target raise to $785.00 at Citigroup, suggesting market confidence. MPWR reported a significant earnings surge with Q1 revenue reaching US$638 Million, and earnings surpassing expectations. The company's EVP recently sold $8,412,000.00 in stock, and a securities fraud lawsuit has been announced by The Schall Law Firm. Despite a recent 5% stock drop post-Q1 earnings beat, cumulative growth over the years is impressive, showing that an investment of $100 fifteen years ago would be worth a significant sum today.
Monolithic Power Systems MPWR News Analytics from Fri, 28 Feb 2025 08:00:00 GMT to Sat, 07 Jun 2025 10:59:19 GMT -
Rating 6
- Innovation 8
- Information 8
- Rumor -4
